Microbion has reported positive topline results from its Phase II study of pravibismane, a topical treatment for DFI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback